Insider Transactions Reported by 17 Insiders of Ocugen, Inc.

Symbol
OCGN on Nasdaq
Location
Malvern, PA

There are no Buy or Sell transactions made by insiders since 08 Jan 2025

Ocugen, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Shankar Musunuri Chief Executive Officer, Director $7,931,589 02 Jan 2026
Arun Upadhyay Chief Scientific Officer, Head of Research, Development and Medical $273,893 02 Jan 2025
Ramesh Ramachandran Chief Accounting Officer $271,830 02 Jan 2026
Quan Vu Cfo/Cbo $108,355 06 Mar 2023
Jessica Crespo CAO/SVP, Finance $105,445 03 Jan 2023
Sanjay Subramanian Chief Financial Officer $105,215 03 Jan 2022
Kirsten Castillo Director $68,543 05 Jun 2025
Manish Potti Director $47,470 16 Dec 2021
Prabhavathi Fernandes Director $9,095 26 Nov 2024
Huma Qamar Chief Medical Officer $1,073 02 Jan 2025
MARNA C. WHITTINGTON Director 28 Jun 2024
Michael Breininger Title: Interim Chief Accounting Officer; Exhibit List: Exhibit 24.1 - Power of Attorney 15 Sep 2023
Junge Zhang Director 05 Jun 2025
Uday Kompella Director 05 Jun 2025
Satishchandran Chandrasekhar Director 05 Jun 2025
Blaise Coleman Director 05 Jun 2025
Ramesh Kumar Director 09 Jun 2023

Recent Insider Transactions by Companies or Individuals for Ocugen, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.